Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5Breast 3Tumor-Agnostic 2Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Neoplasms 2

Interventions

Paclitaxel 26Carboplatin 25pembrolizumab 22Gemcitabine 22Nivolumab 20Cisplatin 15Bevacizumab 14Docetaxel 13Pemetrexed 12Ipilimumab 12Erlotinib Hydrochloride 12Capecitabine 12Fluorouracil 11Irinotecan 10Afatinib 10eribulin 9BI 6727 9130-nm albumin-bound paclitaxel 9Radiotherapy 8Magnetic Resonance Spectroscopy 8Leucovorin 8Everolimus 8Cyclophosphamide 8Albumin-Bound Paclitaxel 8olaparib 7Oxaliplatin 7lenvatinib 6avelumab 6Trastuzumab 6Cetuximab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Decision Support Techniques × Tumor-Agnostic × Clear all
NCT06191679 2025-01-06

DECIDES B+

Children's Hospital of Philadelphia

Phase NA Completed
117 enrolled 17 charts
Tumor-Agnostic

Neoplasms

NCT01964222 2015-12-07

Health Literacy Intervention for Informed Consent of Cancer Patients Considering Clinical Trial Participation

Washington University School of Medicine

Phase NA Completed
201 enrolled 12 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡